April 17th 2025
These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.
Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.